Recent Quotes (30 days)

You have no recent quotes
chg | %

Stellar Biotechnologies Inc  

(Public, CVE:KLH)   Watch this stock  
Find more results for KLH
1.80
+0.14 (8.43%)
Apr 17 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.67 - 1.83
52 week 0.44 - 2.15
Open 1.68
Vol / Avg. 133,064.00/189,016.00
Mkt cap 140.62M
P/E     -
Div/yield     -
EPS -0.31
Shares 78.12M
Beta 2.64
Inst. own     -

Key stats and ratios

Q3 (Aug '13) 2013
Net profit margin -3153.77% -2729.12%
Operating margin -385.12% -674.37%
EBITD margin - -592.49%
Return on average assets -694.54% -296.04%
Return on average equity - -
Employees 6 -
CDP Score - -

Address

332 East Scott Street
PORT HUENEME, CA 93041
United States - Map
+1-805-4882800 (Phone)
+1-805-4882889 (Fax)

Website links

Description

Stellar Biotechnologies, Inc. (Stellar) is an international biotechnology company. Stellar is engaged in the research, development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH), and related products and technologies. The Company offer Stellar KLH products for preclinical and clinical applications, such as HMW and subunit protein in various grades, formulations and configurations, as well as certain preclinical in vitro diagnostic kits. Its customers include biotechnology and pharmaceutical companies, academic institutions, and clinical research organizations. The Company products include HMW and subunit KLH protein in various grades, formulations and configurations, as well as certain preclinical in vitro diagnostic kits. Products offered include: Stellar KLH Protein for Vaccine Conjugation; Stellar KLH Protein for T-Cell Dependent Antibody Response (TDAR) and Immune Function Testing, and Custom KLH Formulations, Conjugations and Fill Finishes.

Officers and directors

Frank R. Oakes President, Chief Executive Officer, Director
Kathi Niffenegger CPA Chief Financial Officer, Secretary
Catherine Brisson Ph.D. Chief Operating Officer
Herbert S. Chow Ph.D. Chief Technology Officer
Tessie Mary Che Ph.D. Director
Age: 60
Daniel E. Morse Ph.D. Director
Gregory T. Baxter Ph.D. Independent Director
David L. Hill Ph.D. Independent Director
Mayank D. Sampat Independent Director